Samuel Cohen, MD
Otolaryngology · New York
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · New York University · 5,925 clinicians in this group
Hospitals listed: Marinhealth Medical Center · Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cohen’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A165829 · Cancelled
Licence status: Cancelled · since 2019 · New York University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$148,659
Medicare paid this office $148,659 for 439 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of nasal passages using an endoscope | 106 | $23,329 | $149 |
| New patient visit (45+ min) | 178 | $22,547 | $127 |
| Short return visit (20+ min) | 180 | $19,344 | $70 |
| Return visit (30+ min) | 101 | $14,647 | $104 |
| New patient visit (30+ min) | 96 | $7,567 | $79 |
See all 16 services
| Diagnostic exam of nasal passages using an endoscope | 106 | $23,329 | $149 |
| New patient visit (45+ min) | 178 | $22,547 | $127 |
| Short return visit (20+ min) | 180 | $19,344 | $70 |
| Return visit (30+ min) | 101 | $14,647 | $104 |
| New patient visit (30+ min) | 96 | $7,567 | $79 |
| Diagnostic exam of voice box using a flexible endoscope | 64 | $7,474 | $90 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 15 | $4,377 | $208 |
| Removal of impacted ear wax | 73 | $2,902 | $32 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 22 | $2,314 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,314 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,043 | $61 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 26 | $1,040 | $37 |
| Exam of ear using a microscope | 32 | $711 | $22 |
| Comprehensive hearing and speech recognition test | 33 | $651 | $19 |
| Test to assess middle ear function | 27 | $287 | $10 |
| Test for eardrum and muscle function | 12 | $142 | $12 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
439 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 14% · Women 58% · Also on Medicaid 25% · Health risk score 1.22. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 62% · Coronary heart disease 25% · Depression 22% · Chronic kidney disease 21% · Diabetes 19% · COPD 18% · Cancer 16% · Atrial fibrillation 16% · Heart failure 14% · Dementia 6% · Stroke 6%.
The office billed $1,168,154, Medicare allowed $199,964 and paid $148,659; for 1,575 services of 93 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 439 | 1,575 | 75 | 1.22 | $1,168,154 | $148,659 |
| 2023 | 192 | 656 | 74 | 1.32 | $440,389 | $63,118 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| New patient visit (45+ min) | 102 | $13,628 | $134 |
| Diagnostic exam of nasal passages using an endoscope | 58 | $10,872 | $162 |
| New patient visit (30+ min) | 57 | $5,139 | $90 |
| Return visit (30+ min) | 38 | $4,195 | $102 |
| Diagnostic exam of voice box using a flexible endoscope | 31 | $3,597 | $103 |
| Short return visit (20+ min) | 39 | $3,389 | $74 |
| Comprehensive hearing and speech recognition test | 61 | $1,805 | $29 |
| Removal of impacted ear wax | 27 | $1,050 | $35 |
| Test to assess middle ear function | 38 | $570 | $14 |
| Test for eardrum and muscle function | 26 | $442 | $17 |
Medicaid work
$65,114 in 2024
Medicaid paid $65,114 for 816 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFF/OP CNSLTJ NEW/EST MOD 40 | 144 | $22,842 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 142 | $11,187 |
| Short return visit (20+ min) | 280 | $10,999 |
| Diagnostic flexible fiberoptic laryngoscopy | 50 | $6,357 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 42 | $4,974 |
| Return visit (30+ min) | 89 | $4,834 |
| Removal of impacted ear wax | 49 | $2,442 |
| Comprehensive audiometry threshold evaluation and speech recognition | 20 | $1,479 |
| 2024 | 816 | 8 | 38 | $65,114 |
| 2023 | 460 | 7 | 32 | $43,870 |
See the largest Medicaid services in earlier years
2023
| OFF/OP CNSLTJ NEW/EST MOD 40 | 97 | $15,508 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 99 | $11,652 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 71 | $4,743 |
| Diagnostic flexible fiberoptic laryngoscopy | 36 | $4,319 |
| Comprehensive audiometry threshold evaluation and speech recognition | 62 | $3,647 |
| Short return visit (20+ min) | 63 | $2,091 |
| Return visit (30+ min) | 32 | $1,909 |
Drugs they prescribed that Part D paid
$41,638
Pharmacies billed $41,638 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (23 of 441) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
423 generic and 18 brand-name prescriptions · $41,638 in drug cost · 49 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 50 | $2,429 | $49 |
| Fluticasone Propionate | 67 | $901 | $13 |
| Pilocarpine | 12 | $635 | $53 |
| Azelastine | 11 | $239 | $22 |
| Omeprazole | 43 | $207 | $5 |
See all 13 drugs
| Ipratropium | 50 | $2,429 | $49 |
| Fluticasone Propionate | 67 | $901 | $13 |
| Pilocarpine | 12 | $635 | $53 |
| Azelastine | 11 | $239 | $22 |
| Omeprazole | 43 | $207 | $5 |
| Mupirocin | 16 | $171 | $11 |
| Doxycycline Hyclate | 14 | $168 | $12 |
| Amoxicillin-Clavulanate Potass | 13 | $167 | $13 |
| Famotidine | 31 | $143 | $5 |
| Ondansetron Odt | 21 | $140 | $7 |
| Prednisone | 15 | $89 | $6 |
| Oxycodone | 22 | $60 | $3 |
| Cephalexin | 11 | $42 | $4 |
Year by year
| 2024 | 441 | 146 | 5% (23) | 4% | $41,638 |
| 2023 | 153 | 74 | 11% (16) | None | $4,105 |
| 2022 | 38 | 23 | 37% (14) | None | $983 |
| 2021 | 22 | 17 | None | 0% | $164 |
| 2020 | 34 | 17 | 35% (12) | None | $616 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Ipratropium | 16 | $605 | $38 |
| Fluticasone Propionate | 31 | $424 | $14 |
| Omeprazole | 20 | $196 | $10 |
| Oxycodone | 16 | $50 | $3 |
Money from drug and device companies
$387 in 2025
| 2025 | 9 | 14 | None | $387 |
| 2024 | 4 | 11 | None | $308 |
| 2023 | 1 | 1 | None | $45 |
| 2021 | 1 | 1 | None | $24 |
| 2020 | 1 | 1 | None | $21 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $94 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $64 | 2 payments
|
| Optinose US | Xhance | $54 | 2 payments
|
| Smith+Nephew | Tula | $50 | 2 payments
|
| Genzyme | Dupixent | $35 | 1 payment
|
| Aerin Medical | Vivaer Stylus | $27 | 1 payment
|
See all 14 published payments
| Novo Nordisk | Meals · 2025-11-05 | Wegovy | $26 |
| Merck Sharp & Dohme | Meals · 2025-10-13 | Gardasil 9 | $19 |
| Integra LifeSciences | Meals · 2025-08-25 | Acclarent Aera | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-08-15 | Dupixent | $33 |
| Smith+Nephew | Meals · 2025-08-04 | Tula | $19 |
| Optinose US | Meals · 2025-07-29 | Xhance | $24 |
| GlaxoSmithKline | Meals · 2025-07-15 | Nucala | $33 |
| GlaxoSmithKline | Meals · 2025-05-20 | Nucala | $28 |
| Aerin Medical | Meals · 2025-05-20 | Vivaer Stylus | $27 |
| Smith+Nephew | Meals · 2025-05-15 | Tula | $31 |
| Genzyme | Meals · 2025-04-22 | Dupixent | $35 |
| GlaxoSmithKline | Meals · 2025-03-21 | Nucala | $33 |
| Optinose US | Meals · 2025-03-11 | Xhance | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-02-20 | Dupixent | $31 |
See earlier years (2024, 2023, 2021, 2020)
2024: $308
| GlaxoSmithKline | Nucala | $139 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $96 | 3 payments
|
| Integra LifeSciences | Acclarent Aera | $39 | 1 payment
|
| Genzyme | Dupixent | $34 | 1 payment
|
2023: $45
| Stryker | Audion Et Dilation System | $45 | 1 payment
|
2021: $24
| Medtronic | Stealthstation | $24 | 1 payment
|
2020: $21
| Medtronic USA | Fusion | $21 | 1 payment
|
Professional record
- NPI
- 1790282440
- Licence
- CA A165829California A165829: Cancelled
- Group
- New York University
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 171 Delancey St Fl 2, New York, NY, 10002
- NPI first listed
- 2018-04-10
- NPI last updated
- 2025-09-04
- NPI record certified
- 2025-09-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 801 Welch Rd, Palo Alto, CA, 94304 · 1701 4th St Ste 120, Santa Rosa, CA, 95404